Sales & Marketing The future is LIVE marketing – and that matters more than ev... Welcome to 2025, world. Think about it: at this same time, just five short years ago, we were in for the ride of our lives, weren’t we?
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face